Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -120.56 | 35.31 |
PEG Ratio (TTM) | -2.64 | 12.22 |
P/S Ratio (TTM) | 3.78 | 14.57 |
P/B Ratio (TTM) | 12.78 | 18.17 |
P/FCF Ratio (TTM) | 85.87 | 42.17 |
Price to 5YR AVG Earnings Ratio | N/A | 34.96 |
Price to 5YR AVG FCF Ratio | N/A | 60.47 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -6.31% | 12.53% |
ROE (TTM) | -11.27% | -3.83% |
Net Profit Margin (TTM) | -3.10% | 25.54% |
ROIC 5YR AVG | N/A | 5.37% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 11.48% | -22.95% | N/A |
Revenue | 6.30% | 63.70% | N/A |
Net Income | 9.64% | -23.81% | N/A |
Cash Flow | 172.00% | -2,599.10% | N/A |
Health (67%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.27 | 1.39 |
Quick Ratio (TTM) | 2.12 | 1.37 |
D/E Ratio (TTM) | 0.03 | 1.18 |
Interest Coverage (TTM) | -5.59 | 33.69 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 12.66 | 9.05 |
LTL to 5YR AVG FCF | N/A | 5.30 |
Shares Outstanding Growth 5YR AVG | N/A | 0.37% |